C&R Research, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Seoul Korea, Republic of (1997)

Organization Overview

First Clinical Trial
2014
NCT02353039
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

C&R Research, Inc.

Active Ingredients

Drugs in Phase 4 Trials (2)

tenofovir (viread) (1 trial)

tenofovir alafenamide (genvoya) (1 trial)

Drugs in Phase 2 Trials (1)

lonicera japonica (1 trial)

Drugs in Phase 1 Trials (1)

metoclopramide (reglan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Gastritis (Phase 2)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4